About Be The Match BioTherapies

Your trusted partner empowering the discovery, development and delivery of next-generation therapies

Contact our team to start building your solution

Reliable solutions proven throughout the last 30 years to improve cell and gene therapies in any stage of development

Powered by the unrivaled experience, knowledge and global cell collection network of the National Marrow Donor Program®/Be The Match® and in close collaboration with our research partner, the CIBMTR® (Center for International Blood and Marrow Transplant Research®), we partner with global cell and gene therapy industry leaders to deliver high-quality, consistent and compliant therapies to patients in need.

We are the only solutions provider with customizable services to support any stage of the supply chain, prior to the point of patient identification and through patient outcomes data collection.

Whether your therapy is in research, pre-clinical or clinical studies, or commercially available, Be The Match BioTherapies® has the unparalleled industry expertise in designing valuable solutions to advance your therapy.

Cell sourcing solutions
immunogenetics-bioinformatics Created with Sketch. cellular-therapy-source-material Created with Sketch.
Supply chain solutions
collection-network-development-management Created with Sketch. quality-regulatory-services Created with Sketch. cell-delivery-logistics Created with Sketch. personalized-case-management Created with Sketch. matchsource-software Created with Sketch. outcomes-data-collection-analysis Created with Sketch.
Clinical research support
clinical-trial-design Created with Sketch. biorepository-sample-access Created with Sketch. observational-prospective-research Created with Sketch.

Our solutions power industry-leading commercialized therapies and build solid foundations for early-stage therapies advancing to market.

Our in-market portfolio of services includes:

  • Longitudinal outcomes tracking for YESCARTA® through our research partner, the CIBMTR
  • Support for development and management of a nationwide apheresis and marrow collection network, including quality and regulatory audit services, to support an approved commercial CAR-T therapy
  • Collection of marrow and other cell sources as starting material for the development of innovative cellular therapies
  • Custom deployment of MatchSource® software for allogeneic supply chain management
  • Support for multiple clinical trials testing allogeneic cell therapies and GvHD treatments
  • Case management, scheduling and logistics management for contract manufacturing of allogeneic cell therapies
  • Leading efforts to establish international standards across the cell and gene therapy supply chains and outcomes data tracking
  • Development and dissemination of patient and healthcare professional education and resources